Rosoxacin (also known as acrosoxacin tradename Eradacil) is a quinolone antibiotic indicated for the treatment of urinary tract infections and certain sexually transmitted diseases. Rosoxacin is not available in the United States.It was developed by Sanofi-Synthelabo (now part of sanofi-aventis).It is classified as first generation.
This page contains content from the copyrighted Wikipedia article "Rosoxacin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
